A pharmacovigilance study of chronic kidney disease in diabetes mellitus patients with statin treatment by using the US Food and Drug Administration adverse event reporting system
BackgroundStatins were regarded as a main medication for managing hypercholesterolemia. Administration of statin therapy could reduce the incidence of cardiovascular disease in individuals diagnosed with type 2 diabetes mellitus (DM), which was recognized by multipal clinical guidelines. But previou...
Wedi'i Gadw mewn:
Prif Awduron: | , , , , , , |
---|---|
Fformat: | Llyfr |
Cyhoeddwyd: |
Frontiers Media S.A.,
2024-06-01T00:00:00Z.
|
Pynciau: | |
Mynediad Ar-lein: | Connect to this object online. |
Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
Rhyngrwyd
Connect to this object online.3rd Floor Main Library
Rhif Galw: |
A1234.567 |
---|---|
Copi 1 | Ar gael |